+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transcatheter Heart Valve Market by Valve Type, Procedure Type, Technology, Material Type, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Transcatheter Heart Valve Market by Valve Type, Procedure Type, Technology, Material Type, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Transcatheter Heart Valve Market by Valve Type, Procedure Type, Technology, Material Type, End User, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305541
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transcatheter Heart Valve Market is projected to reach USD 6.27 Billion in 2026. It is expected to continue growing at a CAGR of 12.02%, reaching USD 12.43 Billion by 2032.

Transcatheter heart valve therapies, led by transcatheter aortic valve replacement (TAVR/TAVI), have moved from a high-risk surgical alternative to a mainstream structural heart intervention for selected patients with severe symptomatic aortic stenosis. The market is supported by well-established clinical evidence, expanding guideline eligibility, aging demographics, and the need to reduce hospitalization burden in cardiovascular care.

Demand is anchored in measurable epidemiology: the World Health Organization identifies cardiovascular disease as the world’s leading cause of death, while the United Nations projects the global population aged 65 and older to more than double by 2050. Because calcific aortic stenosis and other valve disorders rise sharply with age, transcatheter heart valve adoption is positioned as a durable growth area across hospitals, ambulatory cardiac programs, and integrated health systems.

Transformative Shifts in the Transcatheter Valve Landscape

The transcatheter heart valve landscape is being reshaped by broader indications, next-generation delivery systems, improved imaging, and operator experience. Randomized trials and real-world registries have established TAVR as a guideline-supported option across multiple surgical-risk profiles in appropriately selected patients, shifting the competitive focus from procedural feasibility to long-term durability, lifetime valve management, and patient selection.

Competitive differentiation increasingly depends on low-profile delivery, repositionability, sealing technology to reduce paravalvular leak, predictable coronary access, and compatibility with valve-in-valve procedures. Hospitals are also reorganizing structural heart programs around multidisciplinary heart teams, hybrid operating rooms, advanced CT planning, cerebral protection evaluation, and post-procedure pathways that support shorter length of stay without compromising safety.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative advantage across the transcatheter heart valve value chain. AI-enabled CT segmentation, echocardiography interpretation, annular measurement, calcium scoring, and access-route assessment can reduce planning variability and support more consistent valve sizing. These tools are especially relevant as programs treat older patients with complex anatomy, bicuspid valves, prior bioprostheses, and multivalve disease.

The commercial impact of AI is also expanding into workflow automation, inventory planning, physician training, post-market surveillance, and remote patient monitoring. Industry leaders must align AI development with FDA, EU MDR, and Good Machine Learning Practice expectations, because transparent validation, bias management, cybersecurity, and clinically meaningful endpoints will determine adoption by hospitals and payers.

Key Regional Insights Across Global Markets

North America remains the most mature region for transcatheter heart valves due to established reimbursement, high procedural capacity, clinical registry infrastructure, and rapid adoption of FDA-approved device iterations. The United States anchors regional leadership through broad structural heart programs and registry-based quality tracking, while Canada’s publicly funded system supports access through provincial assessment and hospital capacity planning.

Europe continues to be a major innovation and evidence-generation hub, although EU Medical Device Regulation requirements have increased the importance of post-market clinical follow-up, real-world performance data, and robust technical documentation. Asia-Pacific is the fastest-expanding opportunity base as Japan, China, India, South Korea, and Australia combine aging populations with investments in tertiary cardiac care, advanced imaging, and specialist training. Latin America is led by Brazil and Mexico but remains sensitive to reimbursement constraints, public-private access gaps, and uneven distribution of catheterization laboratories. The Middle East is expanding through advanced cardiac centers in high-income health systems, particularly where national health strategies prioritize minimally invasive cardiovascular care, while Africa’s adoption remains limited by infrastructure, specialist availability, and affordability, creating a need for targeted training, referral networks, and sustainable access models.

Key Group Insights for Strategic Market Prioritization

Within ASEAN, transcatheter heart valve growth is supported by expanding private healthcare networks, medical tourism centers, and investments in tertiary cardiac hospitals, although reimbursement coverage, imaging access, and specialist density differ widely across member states. The GCC benefits from high healthcare spending, hospital modernization, and demand for minimally invasive cardiac procedures, making it attractive for premium transcatheter valve platforms, clinician education partnerships, and regional centers of excellence.

The European Union is shaped by MDR compliance, health technology assessment, evidence-based procurement, and an increasing requirement for long-term clinical follow-up. BRICS markets combine large patient pools, rising cardiovascular disease burden, and expanding hospital infrastructure with price sensitivity and localization priorities, requiring differentiated portfolio, training, and manufacturing strategies. G7 countries set clinical evidence, reimbursement, quality registry, and guideline adoption benchmarks that influence global practice patterns, while NATO member markets reinforce the importance of resilient supply chains, cybersecurity, regulatory alignment, and cross-border medical technology standards for high-value cardiovascular devices.

Key Country Insights in High-Priority Markets

The United States leads global transcatheter heart valve adoption through strong clinical evidence, CMS coverage pathways, FDA-approved device availability, and the STS/ACC TVT Registry, which supports outcomes monitoring and quality improvement. Canada offers stable public reimbursement but requires provincial access planning and capacity coordination. Mexico and Brazil are important Latin American entry points, with adoption concentrated in advanced urban cardiac centers and influenced by public-private financing dynamics, specialist availability, and health system prioritization of structural heart disease.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain significant structural heart programs supported by guideline-based care, established interventional cardiology capacity, and aging populations. Germany’s high procedural capacity and hospital infrastructure remain influential, while France’s evidence-driven reimbursement environment supports structured evaluation of clinical value. The United Kingdom emphasizes health technology assessment and pathway efficiency, Italy and Spain continue to expand access through regional cardiac networks, and Russia presents access, procurement, and supply-chain complexity. In Asia-Pacific, China is scaling local innovation, hospital capacity, and regulatory approvals; India is expanding selective adoption amid affordability and reimbursement constraints; Japan has mature regulatory pathways and strong aging-driven demand; Australia supports evidence-based access through advanced public and private hospital systems; and South Korea combines advanced hospitals, digital health readiness, and rapid uptake of cardiovascular technology.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation beyond initial safety and efficacy, including long-term valve durability, coronary reaccess, valve-in-valve feasibility, stroke reduction, pacemaker rates, paravalvular leak reduction, hemodynamic performance, and outcomes in younger low-risk patients. Clear differentiation is needed as hospitals and payers increasingly evaluate total cost of care, procedural efficiency, length of stay, readmission avoidance, and long-term reintervention risk.

Commercial teams should build region-specific access strategies, invest in heart-team training, strengthen AI-enabled planning capabilities, and ensure supply continuity for valves, delivery systems, and imaging-compatible accessories. Partnerships with registry networks, academic centers, payers, and clinical training institutions can accelerate adoption while supporting transparent post-market surveillance, real-world evidence generation, value-based contracting, and responsible expansion into underpenetrated care settings.

Research Methodology and Data Validation

This executive summary is developed using a triangulated research approach that integrates regulatory databases, clinical guidelines, peer-reviewed trials, post-market registries, reimbursement policies, and demographic datasets. Priority sources include FDA, European regulatory and EU MDR documentation, national health agencies, WHO, UN population data, OECD health indicators, ACC/AHA and ESC/EACTS guidelines, and structural heart registries such as the STS/ACC TVT Registry.

The methodology emphasizes verified, data-backed insights and excludes unsupported market claims, market sizing, market share, or forecasting. Findings are validated through cross-source comparison of clinical evidence, device approvals, access pathways, hospital adoption indicators, demographic drivers, and regional healthcare capacity to ensure that conclusions are commercially relevant, reproducible, and defensible.

Conclusion and Strategic Outlook

The transcatheter heart valve market is entering a more sophisticated phase defined by broader patient eligibility, rising durability expectations, AI-assisted planning, and differentiated reimbursement scrutiny. Growth is no longer driven only by procedural expansion; it increasingly depends on measurable clinical value, workflow efficiency, anatomical precision, and lifetime valve management.

Organizations that combine strong clinical evidence with regional access strategies, intelligent digital tools, resilient supply chains, and physician education will be best positioned to lead. As population aging accelerates and health systems seek less invasive cardiovascular solutions, transcatheter heart valves will remain central to the future of structural heart disease treatment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Transcatheter Heart Valve Market, by Valve Type
7.1. Transcatheter Aortic Valves
7.2. Transcatheter Mitral Valves
7.3. Transcatheter Pulmonary Valves
7.4. Transcatheter Tricuspid Valves
8. Transcatheter Heart Valve Market, by Procedure Type
8.1. Valve Replacement Procedures
8.2. Valve Repair Procedures
9. Transcatheter Heart Valve Market, by Technology
9.1. Balloon-Expandable Technology
9.2. Self-Expanding Technology
9.3. Mechanically Expandable Technology
9.4. Polymer-Based Valve Technology
10. Transcatheter Heart Valve Market, by Material Type
10.1. Nitinol-Based Valves
10.2. Stainless Steel Valves
10.3. Cobalt-Chromium Valves
10.4. Polymer-Based Valves
11. Transcatheter Heart Valve Market, by End User
11.1. Cardiac Catheterization Laboratories
11.2. Hospitals
11.2.1. Public Hospitals
11.2.2. Private Hospitals
11.3. Ambulatory Surgical Centers
12. Transcatheter Heart Valve Market, by Distribution Channel
12.1. Online
12.2. Offline
13. Asia-Pacific Transcatheter Heart Valve Market
14. Europe Transcatheter Heart Valve Market
15. North America Transcatheter Heart Valve Market
16. Latin America Transcatheter Heart Valve Market
17. Africa Transcatheter Heart Valve Market
18. Middle East Transcatheter Heart Valve Market
19. NATO Transcatheter Heart Valve Market
20. G7 Transcatheter Heart Valve Market
21. BRICS Transcatheter Heart Valve Market
22. European Union Transcatheter Heart Valve Market
23. ASEAN Transcatheter Heart Valve Market
24. GCC Transcatheter Heart Valve Market
25. China Transcatheter Heart Valve Market
26. United States Transcatheter Heart Valve Market
27. Japan Transcatheter Heart Valve Market
28. India Transcatheter Heart Valve Market
29. Germany Transcatheter Heart Valve Market
30. United Kingdom Transcatheter Heart Valve Market
31. Australia Transcatheter Heart Valve Market
32. France Transcatheter Heart Valve Market
33. South Korea Transcatheter Heart Valve Market
34. Italy Transcatheter Heart Valve Market
35. Canada Transcatheter Heart Valve Market
36. Russia Transcatheter Heart Valve Market
37. Brazil Transcatheter Heart Valve Market
38. Mexico Transcatheter Heart Valve Market
39. Spain Transcatheter Heart Valve Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Abbott Laboratories
41.2. Anteris Technologies Ltd
41.3. Blue Sail Medical Co., Ltd.
41.4. Boston Scientific Corporation
41.5. Cardiovalve Ltd.
41.6. Colibri Heart Valve, LLC
41.7. Edwards Lifesciences Corporation
41.8. Foldax, Inc.
41.9. HighLife SAS
41.10. JenaValve Technology, Inc.
41.11. LivaNova PLC
41.12. Medtronic plc
41.13. Meril Life Sciences Pvt. Ltd.
41.14. MicroPort CardioFlow Medtech Corporation
41.15. Peijia Medical Limited
41.16. Pi-Cardia Ltd.
41.17. Tioga Cardiovascular
41.18. TRiCares GmbH
41.19. Venus Medtech (Hangzhou) Inc.
41.20. Xeltis B.V.
List of Figures
FIGURE 1. GLOBAL TRANSCATHETER HEART VALVE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL TRANSCATHETER HEART VALVE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL TRANSCATHETER HEART VALVE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL TRANSCATHETER HEART VALVE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TRANSCATHETER HEART VALVE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL TRANSCATHETER HEART VALVE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 25. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TRANSCATHETER HEART VALVE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TRANSCATHETER HEART VALVE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL TRANSCATHETER HEART VALVE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TRANSCATHETER AORTIC VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TRANSCATHETER AORTIC VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TRANSCATHETER AORTIC VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TRANSCATHETER MITRAL VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TRANSCATHETER MITRAL VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TRANSCATHETER MITRAL VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TRANSCATHETER PULMONARY VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TRANSCATHETER PULMONARY VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TRANSCATHETER PULMONARY VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TRANSCATHETER TRICUSPID VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TRANSCATHETER TRICUSPID VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TRANSCATHETER TRICUSPID VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VALVE REPLACEMENT PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VALVE REPLACEMENT PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VALVE REPLACEMENT PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VALVE REPAIR PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VALVE REPAIR PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VALVE REPAIR PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BALLOON-EXPANDABLE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BALLOON-EXPANDABLE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BALLOON-EXPANDABLE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SELF-EXPANDING TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SELF-EXPANDING TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SELF-EXPANDING TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MECHANICALLY EXPANDABLE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MECHANICALLY EXPANDABLE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MECHANICALLY EXPANDABLE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL POLYMER-BASED VALVE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL POLYMER-BASED VALVE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL POLYMER-BASED VALVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NITINOL-BASED VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NITINOL-BASED VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NITINOL-BASED VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL STAINLESS STEEL VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL STAINLESS STEEL VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL STAINLESS STEEL VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COBALT-CHROMIUM VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COBALT-CHROMIUM VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COBALT-CHROMIUM VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL POLYMER-BASED VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL POLYMER-BASED VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL POLYMER-BASED VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CARDIAC CATHETERIZATION LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIAC CATHETERIZATION LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIAC CATHETERIZATION LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 88. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 89. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 92. EUROPE TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 111. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 112. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 114. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 116. AFRICA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 127. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 128. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 129. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 130. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 132. NATO TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 135. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 136. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 138. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 140. G7 TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 143. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 144. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 146. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 148. BRICS TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 159. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 160. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 162. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 167. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 168. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 170. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 172. GCC TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 174. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 175. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 176. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 178. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 180. CHINA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 191. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 192. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 194. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 196. JAPAN TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 198. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 199. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 200. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 202. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 204. INDIA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 207. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 208. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 210. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 212. GERMANY TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 214. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 215. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 216. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 218. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 220. UNITED KINGDOM TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 222. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 223. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 224. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 226. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 228. AUSTRALIA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 231. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 232. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 233. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 234. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 236. FRANCE TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 238. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 239. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 240. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 242. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 244. SOUTH KOREA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 246. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 247. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 248. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 250. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 252. ITALY TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 253. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 254. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 255. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 256. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 258. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 260. CANADA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 263. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 264. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 266. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 268. RUSSIA TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 269. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 270. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 271. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 272. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 273. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 274. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 276. BRAZIL TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 277. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 278. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 279. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 280. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 281. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 282. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 284. MEXICO TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 285. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 286. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
TABLE 287. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 288. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 289. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 290. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 291. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 292. SPAIN TRANSCATHETER HEART VALVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Transcatheter Heart Valve market report include:
  • Abbott Laboratories
  • Anteris Technologies Ltd
  • Blue Sail Medical Co., Ltd.
  • Boston Scientific Corporation
  • Cardiovalve Ltd.
  • Colibri Heart Valve, LLC
  • Edwards Lifesciences Corporation
  • Foldax, Inc.
  • HighLife SAS
  • JenaValve Technology, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort CardioFlow Medtech Corporation
  • Peijia Medical Limited
  • Pi-Cardia Ltd.
  • Tioga Cardiovascular
  • TRiCares GmbH
  • Venus Medtech (Hangzhou) Inc.
  • Xeltis B.V.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.27 Billion
Forecasted Market Value ( USD ) by 2032 $ 12.43 Billion
Compound Annual Growth Rate12.0%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Prosthetic Heart Valves Market - Global Forecast 2026-2032 - Product Image

Prosthetic Heart Valves Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Heart Valve Repair & Replacement Devices Market - Global Forecast 2026-2032 - Product Image

Heart Valve Repair & Replacement Devices Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Transcatheter Heart Valves - Global Strategic Business Report - Product Image

Transcatheter Heart Valves - Global Strategic Business Report

  • Report
  • 247 Pages
  • Global
From
Heart Valve Repair and Replacement Devices - Global Strategic Business Report - Product Image

Heart Valve Repair and Replacement Devices - Global Strategic Business Report

  • Report
  • 446 Pages
  • Global
From
Transcatheter Heart Valve Market Size, Share & Trends Analysis Report by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), Technology (Self-Expanded, Balloon Expanded) and Region with Growth Forecasts, 2025-2033 - Product Image

Transcatheter Heart Valve Market Size, Share & Trends Analysis Report by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), Technology (Self-Expanded, Balloon Expanded) and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From

About the Transcatheter Heart Valve Market

The Transcatheter Heart Valve (THV) market is a segment of the Cardiovascular Devices industry. THV devices are used to replace or repair a patient's heart valve without the need for open-heart surgery. This minimally invasive procedure is often used to treat aortic stenosis, a narrowing of the aortic valve. THV devices are typically made of biocompatible materials such as polyester, nitinol, and polyurethane. They are designed to be inserted through a catheter and deployed in the heart. The THV market is expected to grow due to the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. The market is also driven by the increasing number of clinical trials and the availability of reimbursement policies. Some of the major companies in the THV market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.